There have been 50 recent insider transactions recorded for Avalo Therapeutics, Inc. (AVTX), including 29 buys and 17 sells. Total insider buying was valued at $18.97M and total insider selling at $848.54K.
Notable insiders with recent activity include Sullivan Christopher Ryan, Doyle Mittie, Lind Kevin Robert. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — AVTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-02 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Informative Sell |
1,780 |
$17.57 |
$31.27K |
17,338 |
| 2026-04-01 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Informative Sell |
7,479 |
$16.83 |
$125.84K |
25,318 |
| 2026-04-01 |
Doyle Mittie |
Chief Medical Officer |
Informative Sell |
679 |
$16.00 |
$10.86K |
3,622 |
| 2026-03-31 |
Lind Kevin Robert |
Director |
RSU Award |
1,370 |
$14.93 |
$20.45K |
1,370 |
| 2026-03-31 |
Jain Rita |
Director |
RSU Award |
1,339 |
$14.93 |
$19.99K |
1,339 |
| 2026-03-28 |
Kaplan Gilla |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
3,167 |
| 2026-03-28 |
Neil Garry Arthur |
Chief Executive Officer |
Option Exercise (Sell) |
64,866 |
- |
- |
64,867 |
| 2026-03-28 |
Chan Mitchell |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
3,167 |
| 2026-03-28 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Option Exercise (Sell) |
24,200 |
- |
- |
24,200 |
| 2026-03-28 |
Kantoff Aaron |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
3,167 |
| 2026-03-28 |
Goldman Jonathan |
Director |
Option Exercise |
3,166 |
- |
- |
3,166 |
| 2026-03-28 |
Truex Samantha |
Director |
Option Exercise (Sell) |
3,166 |
- |
- |
3,167 |
| 2026-03-16 |
Doyle Mittie |
Chief Medical Officer |
Informative Sell |
25,492 |
$16.15 |
$411.61K |
3,622 |
| 2026-02-26 |
Neil Garry Arthur |
Chief Executive Officer |
RSU Award |
286,000 |
$17.64 |
$5.05M |
286,000 |
| 2026-02-26 |
Varki Paul |
Chief Legal Officer |
RSU Award |
80,000 |
$17.64 |
$1.41M |
80,000 |
| 2026-02-26 |
Sullivan Christopher Ryan |
Chief Financial Officer |
RSU Award |
105,000 |
$17.64 |
$1.85M |
105,000 |
| 2026-02-26 |
Doyle Mittie |
Chief Medical Officer |
RSU Award |
105,000 |
$17.64 |
$1.85M |
105,000 |
| 2026-02-26 |
Riley Jennifer |
Chief Strategy Officer |
RSU Award |
95,000 |
$17.64 |
$1.68M |
95,000 |
| 2026-02-26 |
Boyd Taylor |
Chief Business Officer |
RSU Award |
95,000 |
$17.64 |
$1.68M |
95,000 |
| 2025-12-31 |
Lind Kevin Robert |
Director |
RSU Award |
848 |
$18.16 |
$15.4K |
848 |
| 2025-12-31 |
Jain Rita |
Director |
RSU Award |
1,043 |
$18.16 |
$18.94K |
1,043 |
| 2025-12-10 |
Varki Paul |
Chief Legal Officer |
Tax Withholding of RSU |
1,016 |
$4.10 |
$4.17K |
3,634 |
| 2025-12-10 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Tax Withholding of RSU |
155 |
$4.10 |
$635.50 |
17,338 |
| 2025-12-10 |
Doyle Mittie |
Chief Medical Officer |
Tax Withholding of RSU |
1,013 |
$4.10 |
$4.15K |
3,622 |
| 2025-12-10 |
Riley Jennifer |
Chief Strategy Officer |
Tax Withholding of RSU |
637 |
$4.10 |
$2.61K |
2,655 |
| 2025-11-14 |
Goldman Jonathan |
Director |
Informative Sell |
3,167 |
$14.30 |
$45.29K |
- |
| 2025-10-01 |
Lind Kevin Robert |
Director |
Unknown |
- |
- |
- |
- |
| 2025-10-01 |
Lind Kevin Robert |
Director |
RSU Award |
40,200 |
$12.96 |
$520.99K |
40,200 |
| 2025-10-01 |
Boyd Taylor |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-10-01 |
Boyd Taylor |
Chief Business Officer |
RSU Award |
275,000 |
$12.96 |
$3.56M |
275,000 |
| 2025-09-30 |
Jain Rita |
Director |
RSU Award |
1,572 |
$12.71 |
$19.98K |
1,572 |
| 2025-06-17 |
Kaplan Gilla |
Director |
RSU Award |
20,100 |
$4.47 |
$89.85K |
20,100 |
| 2025-06-17 |
Heffernan Michael Thomas |
Director |
RSU Award |
29,500 |
$4.47 |
$131.87K |
29,500 |
| 2025-06-17 |
Almenoff June Sherie |
Director |
RSU Award |
20,100 |
$4.47 |
$89.85K |
20,100 |
| 2025-06-17 |
Jain Rita |
Director |
Unknown |
- |
- |
- |
- |
| 2025-06-17 |
Jain Rita |
Director |
RSU Award |
40,200 |
$4.47 |
$179.69K |
40,200 |
| 2025-06-17 |
Chan Mitchell |
Director |
RSU Award |
20,100 |
$4.47 |
$89.85K |
20,100 |
| 2025-06-17 |
Kantoff Aaron |
Director |
RSU Award |
20,100 |
$4.47 |
$89.85K |
20,100 |
| 2025-06-17 |
Goldman Jonathan |
Director |
RSU Award |
20,100 |
$4.47 |
$89.85K |
20,100 |
| 2025-06-17 |
Truex Samantha |
Director |
RSU Award |
20,100 |
$4.47 |
$89.85K |
20,100 |
| 2025-03-28 |
Kaplan Gilla |
Director |
Option Exercise |
3,167 |
- |
- |
3,167 |
| 2025-03-28 |
Almenoff June Sherie |
Director |
Option Exercise |
3,167 |
- |
- |
3,167 |
| 2025-03-28 |
Neil Garry Arthur |
Chief Executive Officer |
Tax Withholding of RSU |
17,787 |
$8.46 |
$150.48K |
47,140 |
| 2025-03-28 |
Chan Mitchell |
Director |
Option Exercise |
3,167 |
- |
- |
3,167 |
| 2025-03-28 |
Sullivan Christopher Ryan |
Chief Financial Officer |
Tax Withholding of RSU |
7,285 |
$8.46 |
$61.63K |
16,921 |
| 2025-03-28 |
Kantoff Aaron |
Director |
Option Exercise |
3,167 |
- |
- |
3,167 |
| 2025-03-28 |
Goldman Jonathan |
Director |
Option Exercise |
3,167 |
- |
- |
3,167 |
| 2025-03-28 |
Truex Samantha |
Director |
Option Exercise |
3,167 |
- |
- |
3,167 |
| 2025-03-25 |
Heffernan Michael Thomas |
Director |
Unknown |
- |
- |
- |
- |
| 2025-03-25 |
Heffernan Michael Thomas |
Director |
RSU Award |
50,000 |
$8.54 |
$427K |
50,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
